N-(3-chlorobenzyl)-4,5-dihydrooxazol-2-amine

ID: ALA2286090

PubChem CID: 76309132

Max Phase: Preclinical

Molecular Formula: C10H11ClN2O

Molecular Weight: 210.66

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Clc1cccc(CNC2=NCCO2)c1

Standard InChI:  InChI=1S/C10H11ClN2O/c11-9-3-1-2-8(6-9)7-13-10-12-4-5-14-10/h1-3,6H,4-5,7H2,(H,12,13)

Standard InChI Key:  SUWXHGUSSAAORJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
   35.8778  -11.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5743  -11.2810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2950  -11.6661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.3219  -12.4829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6777  -12.9845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.9556  -13.7530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7724  -13.7261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9991  -12.9410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1593  -11.3240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4632  -11.7547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4882  -12.5745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2151  -12.9616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9082  -12.5286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7434  -11.3679    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  2  0
  1  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  1  1  0
 10 14  1  0
M  END

Associated Targets(non-human)

oa1 Octopamine receptor (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 210.66Molecular Weight (Monoisotopic): 210.0560AlogP: 1.82#Rotatable Bonds: 2
Polar Surface Area: 33.62Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.91CX LogP: 2.28CX LogD: 2.16
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.81Np Likeness Score: -1.26

References

1. HIRASHIMA A, PAN C, KATAFUCHI Y, TANIGUCHI E, ETO M.  (1996)  Synthesis and Octopaminergic-Agonist Activity of 2-(Arylimino)oxazolidines and 2-(Substituted Benzylamino)-2-oxazolines,  21  (4): [10.1584/jpestics.21.419]

Source